The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 5,674,063 | 1,447,465 | SH | SOLE | 1,447,465 | 0 | 0 | ||
ACCURAY INC | COM | 004397105 | 3,324,814 | 1,222,358 | SH | SOLE | 1,222,358 | 0 | 0 | ||
ACELYRIN INC | COM | 00445A100 | 74,241 | 7,300 | SH | SOLE | 7,300 | 0 | 0 | ||
ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | 734,705 | 76,852 | SH | SOLE | 76,852 | 0 | 0 | ||
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 273,830 | 351,064 | SH | SOLE | 351,064 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 1,091,964 | 797,054 | SH | SOLE | 797,054 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 4,075,518 | 628,938 | SH | SOLE | 628,938 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 2,243,836 | 122,547 | SH | SOLE | 122,547 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 3,997,770 | 222,717 | SH | SOLE | 222,717 | 0 | 0 | ||
ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 | 04351PAD3 | 3,691,250 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 12,754,892 | 136,212 | SH | SOLE | 136,212 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 2,204,378 | 295,493 | SH | SOLE | 295,493 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 5,498,170 | 125,529 | SH | SOLE | 125,529 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 2,162,829 | 928,253 | SH | SOLE | 928,253 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 4,679,470 | 935,894 | SH | SOLE | 935,894 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 2,454,998 | 122,200 | SH | SOLE | 122,200 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 4,616,160 | 652,000 | SH | SOLE | 652,000 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 910,350 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 12,530,945 | 249,521 | SH | SOLE | 249,521 | 0 | 0 | ||
BRAINSWAY LTD | SPONSORED ADS | 10501L106 | 1,746,011 | 432,181 | SH | SOLE | 432,181 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 2,614,814 | 1,307,407 | SH | SOLE | 1,307,407 | 0 | 0 | ||
CEREVEL THERAPEUTICS HOLDINGS INC | COM | 15678U128 | 1,357,826 | 62,200 | SH | SOLE | 62,200 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 1,428,200 | 193,000 | SH | SOLE | 193,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 230,258 | 116,882 | SH | SOLE | 116,882 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 190,838 | 205,202 | SH | SOLE | 205,202 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 1,151,920 | 127,284 | SH | SOLE | 127,284 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 14,127,189 | 479,538 | SH | SOLE | 479,538 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 7,195,901 | 586,463 | SH | SOLE | 586,463 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 6,302,602 | 67,552 | SH | SOLE | 67,552 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 2,976,070 | 519,384 | SH | SOLE | 519,384 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 298,170 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 2,079,046 | 60,175 | SH | SOLE | 60,175 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 1,229,256 | 1,476,052 | SH | SOLE | 1,476,052 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 13,485,144 | 499,820 | SH | SOLE | 499,820 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,317,210 | 83,000 | SH | SOLE | 83,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 863,775 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | ||
INOGEN INC | COM | 45780L104 | 78,300 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
ISHARES NASDAQ BIOTECH INDX | ETF | 464287556 | 12,534,725 | 102,500 | SH | SOLE | 102,500 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 1,079,232 | 98,560 | SH | SOLE | 98,560 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 5,831,273 | 605,532 | SH | SOLE | 605,532 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 8,940,296 | 52,873 | SH | SOLE | 52,873 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 258,189 | 192,678 | SH | SOLE | 192,678 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 2,102,837 | 65,961 | SH | SOLE | 65,961 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 147,251 | 105,179 | SH | SOLE | 105,179 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 5,023,150 | 550,784 | SH | SOLE | 550,784 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,293,123 | 327,373 | SH | SOLE | 327,373 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 1,204,591 | 258,496 | SH | SOLE | 258,496 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 263,040 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | ||
MEDIWOUND LTD | SHS NEW | M68830112 | 2,741,428 | 257,653 | SH | SOLE | 257,653 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 1,241,642 | 962,513 | SH | SOLE | 962,513 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 932,228 | 734,038 | SH | SOLE | 734,038 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 11,433,235 | 484,870 | SH | SOLE | 484,870 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 4,046,158 | 92,887 | SH | SOLE | 92,887 | 0 | 0 | ||
MORPHIC HOLDING INC | COM | 61775R105 | 5,309,347 | 231,748 | SH | SOLE | 231,748 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 8,281,688 | 73,615 | SH | SOLE | 73,615 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 423,518 | 313,717 | SH | SOLE | 313,717 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 538,160 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 214,379 | 166,185 | SH | SOLE | 166,185 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 4,375,623 | 556,695 | SH | SOLE | 556,695 | 0 | 0 | ||
PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 2,208,113 | 67,300 | SH | SOLE | 67,300 | 0 | 0 | ||
PROQR THERAPEUTICS N V | SHS EURO | N71542109 | 1,222,757 | 940,582 | SH | SOLE | 940,582 | 0 | 0 | ||
REGULUS THERAPEUTICS INC | COM | 75915K309 | 1,522,137 | 1,111,049 | SH | SOLE | 1,111,049 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 13,103,546 | 473,394 | SH | SOLE | 473,394 | 0 | 0 | ||
SPDR S&P BIOTECH ETF | ETF | 78464A870 | 41,256,300 | 565,000 | SH | SOLE | 565,000 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 151,250 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 1,288,494 | 570,130 | SH | SOLE | 570,130 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 21,615,275 | 13,680,554 | SH | SOLE | 13,680,554 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 982,284 | 283,079 | SH | SOLE | 283,079 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 6,655,576 | 458,373 | SH | SOLE | 458,373 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 1,050,218 | 265,878 | SH | SOLE | 265,878 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 4,584,105 | 220,708 | SH | SOLE | 220,708 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COM | 88427A107 | 1,917,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 928,740 | 172,308 | SH | SOLE | 172,308 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 3,538,581 | 319,655 | SH | SOLE | 319,655 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 9,583,178 | 280,538 | SH | SOLE | 280,538 | 0 | 0 |